3 completed, 3 withdrawn, 1 active not recruiting, 1 unknown. 8 Phase 2, 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 3, Withdrawn 3, Active not recruiting 1, Unknown 1 |
| Phase 3 | 3 | Completed 2, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Carotid Atherosclerosis: new trials by email Literature Review of Carotid Atherosclerosis trials Research Report on Carotid Atherosclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SIALIDASE INHIBITION AS ANTIATHEROSCLEROTIC THERAPY Placebo, Tertinat - Atherosclerosis, Atheroscleroses, Coronary | Phase 2 | Active not recruiting | Institute for Atherosclerosis Research, Russia | 1228 | 2024-08-29 | 2026-07-20 |
| Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques Sonodynamic therapy (SDT), pseudo-SDT - Carotid Atherosclerosis | Phase 1 / Phase 2 | Withdrawn | First Affiliated Hospital of Harbin Medical University | 2023-09-20 | 2023-09-21 | |
| Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation 18F-FPPRGD2, Positron emission tomography, Computed tomography - Aortic Aneurysm, Abdominal, Carotid Atherosclerosis | Phase 2 | Withdrawn | Stanford University | 2019-10-01 | 2021-05-21 | |
| 99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques 99mTc-Annexin-V-128 uptake on scintigraphy - Carotid Atherosclerosis, Atherosclerotic Plaque | Phase 2 / Phase 3 | Withdrawn | Assistance Publique - Hôpitaux de Paris | 2018-09-01 | 2021-10-20 | |
| Effects of Lutein Supplementation on Subclinical Atherosclerosis Placebo, Lutein group, Combination group - Carotid Atherosclerosis, Carotid Intimal Medial Thickness 1 | Phase 2 / Phase 3 | Completed | Peking University | 192 | 2010-06-01 | 2013-07-22 |
| Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED) Atorvastatin/niacin extended-release, Atorvastatin, Simvastatin - Carotid Atherosclerosis | Phase 2 | Completed | Merck Sharp & Dohme LLC | 100 | 2009-04-01 | 2015-09-30 |
| Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis Inflaminat, Placebo - Carotid Atherosclerosis | Phase 2 | Unknown | Institute for Atherosclerosis Research, Russia | 300 | 2007-09-01 | 2012-12-06 |
| ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial" Over-the-wire & Rapid Exchange ACCULINK (tm) Carotid Stent & ACCUNET (tm) embolic protection system - Carotid Atherosclerosis, Carotid Artery Disease | Phase 2 / Phase 3 | Completed | Abbott Medical Devices | 581 | 2000-05-01 | 2008-09-12 |
Carotid Artery Diseases (8) · Atherosclerosis (4) · Inflammation (2) · Aortic Aneurysm, Abdominal (1) · Carotid Intimal Medial Thickness 1 (1) · Carotid Stenosis (1) · Coronary Artery Disease (1) · Plaque, Atherosclerotic (1)
Brain Diseases (8) · Cardiovascular Diseases (8) · Central Nervous System Diseases (8) · Cerebrovascular Disorders (8) · Nervous System Diseases (8) · Vascular Diseases (8) · Arterial Occlusive Diseases (4) · Arteriosclerosis (4) · Pathological Conditions, Signs and Symptoms (3) · Pathologic Processes (2) · Aneurysm (1) · Aortic Aneurysm (1) · Aortic Diseases (1) · Coronary Disease (1) · Heart Diseases (1)
Atorvastatin (1) · FPP(RGD)2 (1) · Magnetic Resonance Imaging (1) · Niacin (1) · Positron-Emission Tomography (1) · Simvastatin (1) · Tomography, Emission-Computed (1)
Institute for Atherosclerosis Research, Russia (2) · Abbott Medical Devices (1) · Assistance Publique - Hôpitaux de Paris (1) · First Affiliated Hospital of Harbin Medical University (1) · Merck Sharp & Dohme LLC (1) · Peking University (1) · Stanford University (1)
China (2) · Russia (2) · United States (1)
Alexander N. Orekhov, Prof., PhD, DSci (1) · L. Nelson Hopkins, M.D. (1) · Mark H. Wholey, MD (1) · Michael V. McConnell, MD, MSEE (1) · Xiaoming Lin, M.M. (1)
2017 (1)